Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 202
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT06357910 | A Study to Evaluate the Pharmacokinetics and Safety Between HCP2303 and Co-administration of Each Component in Healthy Volunteers Under Fed Conditions | ||
| NCT01491217 | A Study of Oraxol® in Gastric Cancer Patients | ||
| NCT03496298 | Effect of Efpeglenatide on Cardiovascular Outcomes | ||
| NCT05024721 | Study to Evaluate the Efficacy and Safety of HIP2101 in Patients With Acute or Chronic Gastritis | ||
| NCT05656092 | A Study to Evaluate the Effiacy and Safety of HIP0612 in Patients With Gastric Ulcer | ||
| NCT03332836 | Multiple Ascending Dose Study of HM12460A in Type 2 Diabetes Mellitus | ||
| NCT01447797 | A Bioequivalence Study Comparing Irbesartan/Atorvastatin Combination Tablet With Coadministration of Irbesartan and Atorvastatin | ||
| NCT01491503 | A Drug Interaction Study of Montelukast and Levocetirizine | ||
| NCT01828359 | The Efficacy and Safety Study of Anti-hypertension Combination Drug in Patients Uncontrolled With Monotherapy. | ||
| NCT01564875 | Efficacy and Safety of Simvast Controlled Release (CR) and Zocor in Chronic Kidney Disease(CKD) Stage 3, 4 and 5 Patients With Hyperlipidemia | ||
| NCT05723549 | A Study to Evaluate the PK, Safety and Tolerability of HCP1803. | ||
| NCT06438172 | A Study to Evaluate Efficacy and Safety of HCP1803 Compared to RLD2001-1 in Patients with Essential Hypertension | ||
| NCT02057172 | Glycaemic Control of Weekly LAPS-Exendin Versus Placebo in Subjects of Type 2 Diabetes | ||
| NCT05487560 | An Observational Study to Evaluate the Incidence of MACCE According to Time Interval of Taking Medication in Patients With Acute Coronary Syndrome or Cerebral Infarction Who Received DAPT for the Secondary Prevention and Esomezol Cap for the Prevention of Gastrointestinal Bleeding | ||
| NCT04032782 | A First-in-Human, Study to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HM15136(Efpegerglucagon) in Healthy Subjects | ||
| NCT00940667 | Efficacy/Safety of Amlodipine Plus Losartan Versus Amlodipine in Patients With Essential Hypertension | ||
| NCT01864863 | To Compare the Pharmacokinetics of Traclear 62.5 mg Tablets and HGP1206 125mg 1 Tablet in Healthy Male Volunteers | ||
| NCT01127217 | Efficacy/Safety of Amlodipine Plus Losartan Versus Amlodipine in Patients With Stage 2 Hypertension | ||
| NCT05845489 | Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- CloPidogREl for Primary preVENTION (HOST-PREVENTION) | ||
| NCT00979563 | Clinical Trial to Evaluate Safety and Tolerability of OratecanTM in Patients With Advanced Solid Malignancies | ||
| NCT01555398 | Clinical Trial to Evaluate the Effect of Food on the Pharmacokinetic Characteristics of HIP0901 Capsule | ||
| NCT01765478 | Safety,PK/PD, Food Effect Study of Orally Administered HM71224 in Healthy Adult Male Volunteers | ||
| NCT04829149 | Statin Monotherapy and Rosuzet Tab.(Rosuvastatin/Ezetimibe) Administration in Patients With Dyslipidemia in Korea | ||
| NCT04946903 | A Study to Evaluate the Pharmacokinetics and Safety Between HCP1902 and Co-administration of RLD2007, RLD2008 | ||
| NCT02418689 | Poziotinib in Patients With HER2+ Recurrent Stage IV BC Who Have Received at Least 2 Prior HER2-directed Regimens | ||
| NCT05737082 | A Study to Evaluate the Pharmacokinetics and Safety Between HCP2201 and Co-administration of Each Component in Healty Male Volunteers | ||
| NCT04967014 | Study to Evaluate the Safety and Pharmacodynamic/Pharmacokinetic Characteristics of HIP2101 in Healthy Volunteers | ||
| NCT01724814 | A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12460A | ||
| NCT02057887 | Safety,Tolerability and Pharmacokinetic Study of Recombinant Human Interferon Alfa 2B in Chronic Hepatitis C Patients (HM10660A) | ||
| NCT04324905 | Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics of HIP1802 to HGP1705 in Healthy Volunteers | ||
| NCT03826641 | A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1801 in Healthy Subjects | ||
| NCT06595004 | A Study to Evaluate the Efficacy and Safety of HCP1004 in Chronic Low-Back Pain Patients | ||
| NCT02899455 | Clinical Efficacy and Safety Evaluation of Co-administered HGP0904, HGP0608 and HGP0816 in Patients With Hypertension and Dyslipidemia | ||
| NCT02941796 | Pharmacokinetics and Safety of HCP1105 and Co-administration of HGP0918, HGP0816 in Healthy Male Volunteers | ||
| NCT02667938 | A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of HCP1303 Capsules | ||
| NCT06174779 | A Study to Evaluate Efficacy and Safety of HM11260C in Adult Obesity Patients Without Diabetes Mellitus | ||
| NCT04505436 | Study to Evaluate Efficacy, Safety and Tolerability of HM15211(Efocipegtrutide) in Subjects | ||
| NCT00942344 | Efficacy and Safety of Amlodipine and Losartan in Patients With Essential Hypertension | ||
| NCT02140489 | Evaluating a Pharmacokinetic Drug Interaction Between Amlodipine/Losartan and Rosuvastatin | ||
| NCT04764201 | The Pharmacokinetic Characteristics and Safety Between HIP2001 and HGP2001 in Healthy Volunteers | ||
| NCT05450575 | An Observational Study to Evaluate Effectiveness and Safety of Amosartan Q Tablet | ||
| NCT01718847 | NOV120101 Phase 2 Study in NSCLC Patients With Aquired Resistance to 1st Generation EGFR Tyrosine Kinase Inhibitors | ||
| NCT07219589 | A SAD Study of HM17321 in Healthy Adult Participants | ||
| NCT02545829 | Evaluating the Bioequivalence of HIP1302, HGP1406 | ||
| NCT04044170 | Poziotinib in Patients With NSCLC Having EGFR or HER2 Exon 20 Insertion Mutation | ||
| NCT06346184 | A Study to Evaluate the Pharmacokinetics and Safety Between HCP2303 and Co-administration of Each Component in Healthy Volunteers | ||
| NCT02059564 | A Phase 1b Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus | ||
| NCT05548387 | A Study to Evaluate the Pharmacokinetics and Safety Between HCP2202 and Co-administration of Each Component in Healthy Volunteers | ||
| NCT02405065 | Clinical Trial to Evaluate Safety, Tolerability and Pharmacokinetics and Anti-tumor Activity of HM95573 | ||
| NCT01588145 | Phase I/II Trial to Evaluate Safety, Tolerability and Pharmacokinetic Profile of HM61713 in NSCLC Patients |
